FibroBiologics voldoet weer aan alle Nasdaq-noteringsregels

FibroBiologics (FBLG) has announced that it is now fully compliant with all Nasdaq listing requirements. The company had previously faced a compliance issue with the exchange. No further details about the nature of the deficiency or the steps taken to resolve it are available at this time.